Open AccessAdjuvant I-131 therapy for T0–3 N1b M0 differentiated thyroid cancer with many (≥ 5) positive nodes
Author(s) -
E. Charles Fortune,
Catherine E. Mercado,
Peter A. Drew,
Christopher G. Morris,
Robert J. Amdur
Publication year - 2022
Publication title -
reports of practical oncology and radiotherapy
Language(s) - English
Resource type - Journals
eISSN - 2083-4640
pISSN - 1507-1367
DOI - 10.5603/rpor.a2022.0010
Subject(s) - thyroid cancer , medicine , radioiodine therapy , adjuvant , thyroid , oncology , adjuvant therapy , cancer
In patients with well-differentiated thyroid cancer, there is controversy about the prognostic importance of a large number of positive neck nodes and the potential value of radioiodine therapy. The purpose of this study was to evaluate this issue in the group of patients for whom it is most clinically important - those with classic histology and favorable T and M stage.